REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,591,249 | +84.5% | 201,996 | +78.3% | 0.00% | +100.0% |
| Q2 2023 | $3,030,829 | +148.6% | 113,302 | +101.3% | 0.00% | – |
| Q1 2023 | $1,219,328 | +412.3% | 56,294 | +463.3% | 0.00% | – |
| Q4 2022 | $238,033 | -42.6% | 9,993 | -52.5% | 0.00% | – |
| Q3 2022 | $415,000 | +36.5% | 21,027 | +34.9% | 0.00% | – |
| Q2 2022 | $304,000 | -90.1% | 15,584 | -87.1% | 0.00% | -100.0% |
| Q1 2022 | $3,080,000 | +841.9% | 120,750 | +1595.5% | 0.00% | – |
| Q1 2021 | $327,000 | – | 7,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 685,011 | $13,508,000 | 35.31% |
| TRV GP III, LLC | 3,604,130 | $71,073,000 | 31.03% |
| Nextech Invest Ltd. | 4,189,529 | $82,618,000 | 26.68% |
| Column Group LLC | 4,577,840 | $90,275,000 | 19.98% |
| Ponoi Management, LLC | 685,011 | $13,508,000 | 18.44% |
| TRV GP IV, LLC | 1,419,900 | $28,000,000 | 16.36% |
| Boxer Capital, LLC | 3,984,264 | $78,570,000 | 4.42% |
| Casdin Capital, LLC | 2,522,300 | $49,740,000 | 3.27% |
| Cormorant Asset Management, LP | 1,995,066 | $39,343,000 | 2.75% |
| BVF INC/IL | 3,255,588 | $64,200,000 | 2.65% |